Sweet syndrome: a rare feature of ANCA-associated vasculitis or unusual consequence of azathioprine-induced treatment

被引：0
|
作者：
A. U. Arun Kumar
Mohamed E. Elsayed
Ahmed Alghali
Alaa A. Ali
Husham Mohamed
Wael Hussein
Catriona Hackett
Niamh Leonard
Austin G. Stack
机构：
[1] University Hospital Limerick,Division of Nephrology, Department of Medicine
[2] University of Limerick,Graduate Entry Medical School
[3] University Hospital Limerick,Division of Dermatology, Department of Medicine
[4] St James Hospital,Department of Pathology
[5] University of Limerick,Health Research Institute
来源：
Allergy, Asthma & Clinical Immunology | / 14卷
关键词：
Sweet ’s Syndrome; ANCA Vasculitis; Anti-neutrophil Cytoplasmic Antibody (ANCA); Active Urinary Sediment; Standard Immunosuppressive Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] DAH: A Rare Presentation of Anca-Associated Vasculitis
    Sheriff, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [22] A rare case of ANCA-associated cerebral vasculitis
    Massaro, Maria Grazia
    Cianci, Rossella
    Lozupone, Emilio
    Trombatore, Pietro
    Gambassi, Giovanni
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (04) : 1085 - 1087
  • [23] Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis THE AUTHORS REPLY
    Pagnoux, Christian
    Guillevin, Loic
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13): : 1359 - 1359
  • [24] Avacopan for the treatment of ANCA-associated vasculitis
    Osman, Mohammed
    Cohen Tervaert, Jan Willem
    Pagnoux, Christian
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (07) : 717 - 726
  • [25] Progress in treatment of ANCA-associated vasculitis
    Rona M Smith
    Rachel B Jones
    David RW Jayne
    Arthritis Research & Therapy, 14
  • [26] Treatment of Relapses in ANCA-Associated Vasculitis
    McClure, Mark
    Jones, Rachel B.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (07): : 967 - 969
  • [27] Comparison of Mizoribine with Azathioprine in Efficacy and Safety for ANCA-Associated Vasculitis
    Fukui, Sho
    Kawaai, Satoshi
    Kidoguchi, Genki
    Nakai, Takehiro
    Ozawa, Hiroki
    Koido, Ayako
    Ikeda, Yukihiko
    Suda, Masei
    Yanaoka, Haruyuki
    Shimizu, Hisanori
    Tamaki, Hiromichi
    Tsuda, Tokutaro
    Kishimoto, Mitsumasa
    Yamaguchi, Kenichi
    Okada, Masato
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [28] Treatment Strategies in ANCA-Associated Vasculitis
    Emejuaiwe, Nkechinyere
    CURRENT RHEUMATOLOGY REPORTS, 2019, 21 (07)
  • [29] Obinutuzumab as treatment for ANCA-associated vasculitis
    Amudala, Naomi A.
    Boukhlal, Sara
    Sheridan, Brittany
    Langford, Carol A.
    Geara, Abdallah
    Merkel, Peter A.
    Cornec, Divi
    RHEUMATOLOGY, 2022, 61 (09) : 3814 - 3817
  • [30] Avacopan in the treatment of ANCA-associated vasculitis
    Tesar, Vladimir
    Hruskova, Zdenka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (05) : 491 - 496
12345